314 related articles for article (PubMed ID: 2651479)
1. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.
Jacob R; Barrett E; Plewe G; Fagin KD; Sherwin RS
J Clin Invest; 1989 May; 83(5):1717-23. PubMed ID: 2651479
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
Laager R; Ninnis R; Keller U
J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
[TBL] [Abstract][Full Text] [Related]
3. The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.
Douglas RG; Gluckman PD; Ball K; Breier B; Shaw JH
J Clin Invest; 1991 Aug; 88(2):614-22. PubMed ID: 1864971
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats.
Jacob RJ; Sherwin RS; Bowen L; Fryburg D; Fagin KD; Tamborlane WV; Shulman GI
Am J Physiol; 1991 Feb; 260(2 Pt 1):E262-8. PubMed ID: 1996629
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human IGF-I on glucose and leucine kinetics in men.
Elahi D; McAloon-Dyke M; Fukagawa NK; Sclater AL; Wong GA; Shannon RP; Minaker KL; Miles JM; Rubenstein AH; Vandepol CJ
Am J Physiol; 1993 Dec; 265(6 Pt 1):E831-8. PubMed ID: 8279537
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of insulin-like growth factor-I administration on the protein-sparing effects of total parenteral nutrition in fasted lambs.
Koea JB; Douglas RG; Breier BH; Shaw JH; Gluckman PD
Endocrinology; 1992 Aug; 131(2):643-8. PubMed ID: 1639012
[TBL] [Abstract][Full Text] [Related]
7. Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal.
Hawkins M; Barzilai N; Chen W; Angelov I; Hu M; Cohen P; Rossetti L
Diabetes; 1996 Dec; 45(12):1734-43. PubMed ID: 8922359
[TBL] [Abstract][Full Text] [Related]
8. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
[TBL] [Abstract][Full Text] [Related]
9. Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man.
Turkalj I; Keller U; Ninnis R; Vosmeer S; Stauffacher W
J Clin Endocrinol Metab; 1992 Nov; 75(5):1186-91. PubMed ID: 1430077
[TBL] [Abstract][Full Text] [Related]
10. IGF-I stimulation of muscle protein synthesis in the awake rat: permissive role of insulin and amino acids.
Jacob R; Hu X; Niederstock D; Hasan S; McNulty PH; Sherwin RS; Young LH
Am J Physiol; 1996 Jan; 270(1 Pt 1):E60-6. PubMed ID: 8772474
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor stimulates glycogen synthesis in fetal rat hepatocytes: comparison with the glycogenic effects of insulin-like growth factor I and insulin.
Freemark M
Endocrinology; 1986 Aug; 119(2):522-6. PubMed ID: 3525120
[TBL] [Abstract][Full Text] [Related]
12. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism.
Boulware SD; Tamborlane WV; Matthews LS; Sherwin RS
Am J Physiol; 1992 Jan; 262(1 Pt 1):E130-3. PubMed ID: 1733244
[TBL] [Abstract][Full Text] [Related]
13. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G
Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of human recombinant insulin-like growth factor I and insulin on plasma amino acid concentrations and leucine kinetics in humans.
Giordano M; Castellino P; Carroll CA; DeFronzo RA
Diabetologia; 1995 Jun; 38(6):732-8. PubMed ID: 7672498
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I and insulin have no differential effects on glucose production and utilization under conditions of hyperglycemia.
Giacca A; Fisher SJ; Shi ZQ; Gupta R; Lickley HL; Skottner A; Anderson GH; Efendic S; Vranic M
Endocrinology; 1994 May; 134(5):2251-8. PubMed ID: 8156929
[TBL] [Abstract][Full Text] [Related]
16. rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery.
Mauras N; Martha PM; Quarmby V; Haymond MW
Am J Physiol; 1997 Apr; 272(4 Pt 1):E628-33. PubMed ID: 9142884
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.
Simpson HL; Jackson NC; Shojaee-Moradie F; Jones RH; Russell-Jones DL; Sönksen PH; Dunger DB; Umpleby AM
J Clin Endocrinol Metab; 2004 Jan; 89(1):425-32. PubMed ID: 14715881
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma.
Chung J; Henry RR
J Clin Endocrinol Metab; 1996 Mar; 81(3):919-25. PubMed ID: 8772551
[TBL] [Abstract][Full Text] [Related]
19. Effects of insulin-like growth factor I on glucose metabolism in rats with liver cirrhosis.
Petersen KF; Jacob R; West AB; Sherwin RS; Shulman GI
Am J Physiol; 1997 Dec; 273(6):E1189-93. PubMed ID: 9435535
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.
Di Cola G; Cool MH; Accili D
J Clin Invest; 1997 May; 99(10):2538-44. PubMed ID: 9153298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
